Search

Although many foods contain toxins as a naturally-occurring constituent or, are formed as the result of handling or processing, the incidence of adverse reactions to food is relatively low. The low incidence of adverse effects is the result of some pragmatic solutions by the US Food and Drug Administration (FDA) and other regulatory agencies through the creative use of specifications, action levels, tolerances, warning labels and prohibitions. Manufacturers have also played a role by setting limits on certain substances and developing mitigation procedures for process-induced toxins. Regardless of measures taken by regulators and food producers to protect consumers from natural food toxins, consumption of small levels of these materials is unavoidable. Although the risk for toxicity due to consumption of food toxins is fairly low, there is always the possibility of toxicity due to contamination, overconsumption, allergy or an unpredictable idiosyncratic response. The purpose of this review is to provide a toxicological and regulatory overview of some of the toxins present in some commonly consumed foods, and where possible, discuss the steps that have been taken to reduce consumer exposure, many of which are possible because of the unique process of food regulation in the United States. [ABSTRACT FROM AUTHOR]

Rodgers, John H., Jr., Brenda M. Johnson, and West M. Bishop, 2010. Comparison of Three Algaecides for Controlling the Density of Prymnesium parvum. Journal of the American Water Resources Association (JAWRA) 46(1):153-160. DOI: 10.1111/j.1752-1688.2009.00399.x Prymnesium parvum has become more prevalent in water resources of the southern United States. As the potential impacts of P. parvum are relatively well known, especially its capability to severely affect fish, managers have sought efficacious, environmentally sound, and socially acceptable strategies for mitigating this noxious species. Laboratory testing was used to identify an effective algaecide for control of P. parvum from Texas, Arizona, Florida, North Carolina, and South Carolina. Cutrine®-Plus at 0.2 mg Cu/l significantly decreased the density of P. parvum in samples from all of these locations. Both copper sulfate and Phycomycin® were less effective for controlling the population growth of P. parvum. The predicted response from the laboratory study was confirmed in the field at the Arizona site. Strategic use of Cutrine®-Plus in larger water resources could provide toxin-free refugia to allow some fish to survive and repopulate the water resource when the golden alga infestation abates. [ABSTRACT FROM AUTHOR]

In 2001, numerous Ya Li pear fruit from China with a disease apparently caused by an Alternariu sp. were intercepted at U.S. ports, raising concern because tile disease was unknown in the United States. To identify the etiologic agent of tile disease, single-spore cultures were established from intercepted fruit and were characterized by pathogenicity to wounded fruit, morphology, and sporulation pattern on three agar media, random amplified polymorphic DNA fragment pattern analysis, and species specific polymerase chain reaction (PCR). These data indicated that the disease likely was caused by more than one species of Alternaria, and that none of the isolates from intercepted Ya Li fruit was A. alternaria or A. gaisen. A species specific PCR assay for A. gaisen demonstrated that no isolate from Ya Li was A. gaisen. A PCR assay for the AMT gene demonstrated that no isolate from Ya Li was A, ‘mali’. Because of these data and the absence of a description to accommodate at least one of the taxa involved, A. yaliinficiens R. G. Roberts sp. nov. is described, and the disease caused by this and other species of Alternaria on Ya Li pear fiom China is referred to as ‘chocolate spot of Ya Li pear’ to distinguish it from black spot of Japanese pear. [ABSTRACT FROM AUTHOR]

Florida red tides impose both an economic and health impact on the state. The purpose of this research was to examine the effectiveness of ozone to reduce the numbers of Florida red tide organism (Karenia brevis Davis) and its associated toxins in an artificial seawater environment. The results obtained in this experiment showed an approximate 1.25 log10 unit reduction in the major toxin groups recovered after 10 min of ozone exposure (approximately 135 mg). In initial trials, K. brevis toxins were extracted and reintroduced into an artificial seawater (ASW) media. Subsequent experiments exposed whole cell K. brevis culture to ozone treatment. Samples from both experiments displayed approximately 1.10 log10 unit reduction in total toxin and an approximate 1.25 log10 unit reduction in three of the six major toxins associated with K. brevis (PxTx-1, -2, -9). The reduction in toxin concentration, as measured by high performance liquid chromatography (HPLC) analysis, displayed a positive correlation with the reduction of toxicity as determined by a fish (Cyprinodon variegatus) bioassay. Despite large total doses of ozone applied, as compared to levels that might be found at a commercial ozonation facility, some toxins were still recoverable by HPLC after ozone treatment. [Copyright &y& Elsevier]

Most hazardous-waste sites are located in urban areas populated by disproportionate numbers of children, minorities, and poor people who, as a result, face more severe pollution threats and environmental-health inequalities. Partly to address this harm, in 2017 the United Nations unanimously endorsed the New Urban Agenda, which includes redeveloping urban-infill-toxic-waste sites. However, no systematic, independent analyses assess the public-health adequacy of such hazardous-facility redevelopments. Our objective is to provide a preliminary data-quality assessment (PDQA) of urban-infill-toxic-site testing, conducted by private redevelopers, including whether it adequately addresses pollution threats. To this end, we used two qualitative, weight-of-evidence methods . Method 1 employs nine criteria to select assessments for PDQA and help control for confounders. To conduct PDQA, Method 2 uses three US Environmental Protection Agency standards-the temporal, geographical, and technological representativeness of sampling. Our Method 1 results reveal four current toxic-site assessments (by CBRE/Trammell Crow, the world's largest commercial developer); at all of these sites the main risk drivers are solvents, volatile organic compounds, including trichloroethylene. Our Method 2 results indicate that all four assessments violate most PDQA standards and systematically underestimate health risk. These results reveal environmental injustice, disproportionate health threats to children/minorities/poor people at all four sites. Although preliminary, our conclusion is that alleviating harm and environmental-health inequalities posed by urban-infill-toxic-site pollution may require improving both the testing/cleanup/redevelopment requirements of the New Urban Agenda and the regulatory oversight of assessment and remediation performed by private redevelopers., Competing Interests: The authors declare no conflict of interest.

In recent years, immunotherapy has been the focus of great interest to researchers, clinicians, and the general public. Traditionally cancer therapy has been thought to be limited to surgery, radiation therapy, or chemotherapy. Some clinicians have considered it the so-called fifth pillar of cancer therapy, following surgery, cytotoxic chemotherapy, radiation, and targeted therapy. However, the origins of immunotherapy in cancer treatment reach back at least into the nineteenth century. This article reviews the origins, development, and future of immunotherapy., (Copyright © 2020 Elsevier Inc. All rights reserved.)

INTRODUCTIONIn 2010, we published an initial Point-Counterpoint on the laboratory diagnosis of Clostridium difficile infection (CDI). At that time, nucleic acid amplification tests (NAATs) were just becoming commercially available, and the idea of algorithmic approaches to CDI was being explored. Now, there are numerous NAATs in the marketplace, and based on recent proficiency test surveys, they have become the predominant method used for CDI diagnosis in the United States. At the same time, there is a body of literature that suggests that NAATs lack clinical specificity and thus inflate CDI rates. Hospital administrators are taking note of institutional CDI rates because they are publicly reported. They have become an important metric impacting hospital safety ratings and value-based purchasing; hospitals may have millions of dollars of reimbursement at risk. In this Point-Counterpoint using a frequently asked question approach, Ferric Fang of the University of Washington, who has been a consistent advocate for a NAAT-only approach for CDI diagnosis, will discuss the value of a NAAT-only approach, while Christopher Polage of the University of California Davis and Mark Wilcox of Leeds University, Leeds, United Kingdom, each of whom has recently written important articles on the value of toxin detection in the diagnosis, will discuss the impact of toxin detection in CDI diagnosis., (Copyright © 2017 American Society for Microbiology.)

The best laboratory diagnostic approach to detect Clostridium difficile infection (CDI) is the subject of ongoing debate. In the United States, nucleic acid amplification tests (NAAT) have become the most widely used tests for making this diagnosis. Detection of toxin in stool may be a better predictor of CDI disease and severity. Laboratories that have switched from toxin-based to NAAT-based methods have significantly higher CDI detection rates. The important issue is whether all NAAT-positive patients have CDI or at least some of those patients are excretors of the organism and do not have clinical disease., (Copyright © 2015 Elsevier Inc. All rights reserved.)